Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Correction

Anthem Biosciences Results Correction

Anthem Biosciences clarified minor discrepancies in its FY25-26 financial results. It will file a revised XBRL to include the omitted consolidated EPS.

Source

NSE filing, NSE: ANTHEM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Anthem Biosciences Ltd: key numbers

Share price
₹828.80
Market cap
₹46,678 Cr
Revenue (annual)
₹2,124 Cr
Net profit (annual)
₹591.8 Cr
P/E (TTM)
81.0×Sector 45.9×
Promoter holding
71.40%-0.02% QoQ
FII holding
3.79%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Anthem Biosciences Ltd

All →

Other results correction announcements

All →